Comparison of the effects of dexmedetomidine and sufentanil combination and chloral hydrate in pediatric patients during tumor radiotherapy: a randomized controlled trial
-
摘要:
目的 比较右美托咪定滴鼻联合舒芬太尼和单独使用水合氯醛在儿童肿瘤放射治疗过程中的疗效。 方法 选取2018年11月至2019年9月深圳市人民医院行肿瘤放疗的48例患儿作为研究对象，随机分组为接受右美托咪定滴鼻联合舒芬太尼组（DS组）和口服水合氯醛组（C组）。观察比较两组镇静起效时间、苏醒时间和放射治疗时间，以及镇静前后平均动脉血压（MAP）、心率（HR）和血氧饱和度（SpO2）的变化情况，并统计两组不良反应发生情况。 结果 研究纳入48例患儿，其中DS组24例和C组23例纳入最终分析。与C组相比，DS组患儿恢复时间更短，MAP、HR和不良反应发生率更低。两组患儿用药起效时间、治疗时间的差异无统计学意义（P>0.05）。 结论 右美托咪定滴鼻联合舒芬太尼能安全地应用于儿童肿瘤放射治疗并缩短恢复时间。 Abstract:Objective To compare the effects of dexmedetomidine and sufentanil (DS) combination and chloral hydrate (C) alone in pediatric patients during tumor radiotherapy. Methods In total, 48 children treated with radiotherapy at Shenzhen People's Hospital from November 2018 to September 2019 were enrolled in this study. Changes in sedation onset, recovery, and radiation treatment time and those in mean arterial blood pressure (MAP), heart rate (HR) and oxygen saturation (SpO2) after sedation, and incidence of adverse reactions were recorded. Results Overall, 48 patients (24 in Group DS and 23 in Group C) were ultimately included in the analysis after enrollment. Patients in Group DS had shorter recovery time and lower MAP, HR, and incidence of adverse reactions than those in Group C. The onset and treatment time did not significantly differ between the two groups. Conclusions The use of the combination of dexmedetomidine and sufentanil was safe for pediatric patients during tumor radiotherapy and reduced recovery time. -
Key words:
- dexmedetomidine /
- nasal drops /
- sufentanil /
- children /
- radiotherapy
-
表 1 两组患儿年龄、体重的比较
x±s 
表 2 两组患儿用药起效时间、治疗时间和苏醒时间比较
min，x±s 
表 3 两组患儿镇静期间生命体征比较
x±s 
表 4 两组患儿术中不良反应及镇静成功率比较
例（%） 
-
[1] Wang X, Huang Y, Zheng Z, et al. Metastases to the thyroid gland:A retrospective analysis of 21 patients[J]. J Cancer Res Ther, 2018, 14(7):1515-1518. http://cn.bing.com/academic/profile?id=10ad4f9abf102ef37ae3cda11e808552&encoded=0&v=paper_preview&mkt=zh-cn [2] 康静波.肿瘤精确放射治疗的技术进展与临床应用[J].转化医学杂志, 2016, 5(2):65-69. http://d.old.wanfangdata.com.cn/Periodical/zhyxzz201602002 [3] 邓哲, 许莹.右美托咪定滴鼻镇静在听觉脑干诱发电位检测中的应用研究[J].临床医药实践, 2019, 28(1):3-5. http://d.old.wanfangdata.com.cn/Periodical/sxlcyy201901001 [4] 吴新民, 薛张纲, 马虹, 等.右美托咪定临床应用专家共识(2018)[J].临床麻醉学杂志, 2018, 34(8):820-823. http://d.old.wanfangdata.com.cn/Periodical/lcmzxzz201808025 [5] 卞勇, 姚莹, 王丹, 等.水合氯醛口服复合右美托咪定滴鼻用于小儿核磁共振检查镇静的疗效及安全性评估[J].国际麻醉学与复苏杂志, 2015, 36(12):1080-1085. http://d.old.wanfangdata.com.cn/Periodical/gwyx-mzxyfsfc201512006 [6] 侯卫锋.咪达唑仑与丙泊酚在急诊危重症机械通气患者中应用对比[J].临床医学, 2017, 37(4):50-52. http://d.old.wanfangdata.com.cn/Periodical/lcyx201704021 [7] 中华医学会麻醉学分会.右美托咪定临床应用指导意见(2013)[J].中华麻醉学杂志, 2013, 33(10):1165-1167. http://d.old.wanfangdata.com.cn/Periodical/zhmzxzz98201310001 [8] 黄进荣.右美托咪定滴鼻镇静用于小儿心脏彩色超声中的作用[J].深圳中西医结合杂志, 2019, 29(8):158-159. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=szzxyjhzz201908077 [9] Mahmoud M, Mason KP. Dexmedetomidine:review, update, and future considerations of paediatric perioperative and periprocedural applications and limitationsl[J]. Br J Anaesth, 2015, 115(2):171. http://d.old.wanfangdata.com.cn/Periodical/zgnjzz201612002 [10] 张园, 岳红丽, 梅弘勋, 等.不同剂量右美托咪定滴鼻用于小儿开颅术前镇静效果的比较[J].临床和实验医学杂志, 2015, 14(19):1643-1646. http://d.old.wanfangdata.com.cn/Periodical/lchsyyxzz201519027 [11] Ahmad RA, Amarpal PK, Kinjavdekar P, et al. Potential use of dexmedetomidine for different levels of sedation, analgesia and an-aesthesia in dogs[J]. Vet Med, 2013, 58(2):87-95. https://www.researchgate.net/profile/Raja_Ahmad3/publication/236132028_Potential_use_of_dexmedetomidine_for_different_levels_of_sedation_analgesia_and_anaesthesia_in_dogs/links/0c960526e4987c8547000000.pdf -
点击查看大图
表(4)
计量
- 文章访问数: 149
- HTML全文浏览量: 3
- PDF下载量: 5
- 被引次数: 0
下载:
